Pacira | PCRX - Market Capitalization


Pacira reported $1.09B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Assertio Holdings USD 101M 137M Dec/2023
Astellas Pharma JPY 4.33T 546.23B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Cara Therapeutics USD 46M 23M Jun/2025
Coherus Biosciences USD 278M 184M Jun/2025
Heron Therapeutics USD 145M 6M Sep/2023
Ironwood Pharmaceuticals USD 213M 97M Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Ligand Pharmaceuticals USD 3.42B 1.23B Sep/2025
Nektar Therapeutics USD 113M 4M Sep/2023
Novo Nordisk A/S DKK 1.54T 86.62B Feb/2026
Omeros USD 184M 158M Sep/2023
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Supernus Pharmaceuticals USD 2.92B 67M Feb/2026
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026
Xoma USD 162M 55M Sep/2023
Zoetis USD 57.53B 2.08B Feb/2026